These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 21563869)
21. Suspected neuroleptic catatonia induced by clozapine. Biancosino B; Zanchi P; Agostini M; Grassi L Can J Psychiatry; 2001 Jun; 46(5):458. PubMed ID: 11441795 [No Abstract] [Full Text] [Related]
22. A case report of cholinergic rebound syndrome following abrupt low-dose clozapine discontinuation in a patient with type I bipolar affective disorder. Galova A; Berney P; Desmeules J; Sergentanis I; Besson M BMC Psychiatry; 2019 Feb; 19(1):73. PubMed ID: 30782143 [TBL] [Abstract][Full Text] [Related]
23. Non-Psychosis Symptoms of Clozapine Withdrawal: a Systematic Review. Yee B; Looi JCL; Agaciak M; Allison S; Chan SKW; Bastiampillai T East Asian Arch Psychiatry; 2023 Jun; 33(2):44-64. PubMed ID: 37400227 [TBL] [Abstract][Full Text] [Related]
24. Clozapine monotherapy for catatonic schizophrenia: should clozapine be the treatment of choice, with catatonia rather than psychosis as the main therapeutic index? Dursun SM; Hallak JE; Haddad P; Leahy A; Byrne A; Strickland PL; Anderson IM; Zuardi AW; Deakin JF J Psychopharmacol; 2005 Jul; 19(4):432-3. PubMed ID: 15983003 [No Abstract] [Full Text] [Related]
25. Treatment of clozapine-associated tardive dyskinesia. Lin CC; Bai YM; Chen JY; Wang YC; Liou YJ Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):599-600. PubMed ID: 17920744 [No Abstract] [Full Text] [Related]
26. Clozapine Withdrawal-Induced Malignant Catatonia or Neuroleptic Malignant Syndrome: A Case Report and a Brief Review of the Literature. Belteczki Z; Ujvari J; Dome P Clin Neuropharmacol; 2021 Jul-Aug 01; 44(4):148-153. PubMed ID: 34132673 [TBL] [Abstract][Full Text] [Related]
27. Neuroleptic malignant syndrome and clozapine withdrawal at the same time? Margetić B; Aukst-Margetić B Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jan; 29(1):145-7. PubMed ID: 15610957 [TBL] [Abstract][Full Text] [Related]
28. Withdrawal from clozapine: the "rebound phenomenon". Durst R; Teitelbaum A; Katz G; Knobler HY Isr J Psychiatry Relat Sci; 1999; 36(2):122-8. PubMed ID: 10472746 [TBL] [Abstract][Full Text] [Related]
29. Catatonia and Schizophrenia in a Young Man with Autism Spectrum Disorder and Clozapine-Induced Myocarditis. Gautam M; Sivananthan M; Cotes R; Beach S Harv Rev Psychiatry; 2022 Jul-Aug 01; 30(4):261-269. PubMed ID: 35849743 [No Abstract] [Full Text] [Related]
30. Clozapine withdrawal symptoms after change to sertindole in a schizophrenic patient. Berecz R; Glaub T; Kellermann M; de la Rubia A; Llerena A; Degrell I Pharmacopsychiatry; 2000 Jan; 33(1):42-4. PubMed ID: 10721883 [TBL] [Abstract][Full Text] [Related]
34. Review of withdrawal catatonia: what does this reveal about clozapine? Lander M; Bastiampillai T; Sareen J Transl Psychiatry; 2018 Jul; 8(1):139. PubMed ID: 30065280 [TBL] [Abstract][Full Text] [Related]
35. Immediate recurrence of psychotic symptoms after discontinuation of clozapine: a case report. Tanríverdi N; Yazící KM Biol Psychiatry; 1996 May; 39(9):814-5. PubMed ID: 8731523 [No Abstract] [Full Text] [Related]
36. Successful re-challenge with clozapine following development of clozapine-induced cardiomyopathy. Floreani J; Bastiampillai T Aust N Z J Psychiatry; 2008 Aug; 42(8):747-8. PubMed ID: 18642408 [No Abstract] [Full Text] [Related]